Pantoprazol Omnicals (Pantoprazole Sodium Sesquihydrate)

Pantoprazol Omnicals is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining.
• Erosive oesophagitis: accelerates healing of erosive lesions in the oesophagus.
• Peptic ulcer disease (duoden‑and gastric ulcer): supports ulcer healing and reduces recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder.

• Pantoprazole sodium sesquihydrate selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid production, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Pantoprazol Omnicals may cause adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: loose stools occurring during early treatment.
• Nausea: occasional feeling of stomach upset.
• Abdominal pain: cramp‑like discomfort.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhoea.
• Acute interstitial nephritis: kidney inflammation with reduced urine output.
• Severe hypersensitivity: rash, itching, swelling, or anaphylaxis.
• Osteoporosis‑related fractures: increased risk of hip or vertebral fractures with long‑term use.
• Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat, or seizures.

When prescribing Pantoprazol Omnicals, clinicians should consider several safety aspects:

• Renal impairment: dose adjustment may be required in patients with reduced kidney function.
• Hepatic impairment: use with caution in moderate to severe liver disease.
• Long‑term therapy: monitor bone health and magnesium levels during prolonged use.
• Drug‑induced nutrient absorption: be aware of reduced absorption of vitamin B12 and iron.
• Pregnancy and lactation: evaluate risk‑benefit ratio before use.
• Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Pantoprazole can interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH.
• HIV protease inhibitors (ritonavir, atazanavir): decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR.
• Methotrexate: reduced renal clearance may raise serum levels.
• Digoxin: slight increase in serum concentration.
• Oral contraceptives: possible decrease in efficacy.